Catalyst Wire Dossier Catalyst Wire Dossier

GEM-SYS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEM-SYS, covering 2024-07-17 to 2024-07-17. Get the full timeline:

Most recent: Clinical Trial Update: GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

See pricing